Cyclopharm Limited Stock
Stocks
CYC
AU000000CYC5
Advanced Medical Equipment & Technology
OTC Markets Traded|
Market Closed -
Australian S.E.
04:10:11 30/10/26 pm AEDT
|
5-day change | 1st Jan Change | ||
| 0.4250 AUD | +10.39% |
|
+18.06% | -56.63% |
| 29/10 | Cyclopharm Limited, Q3 2026 Earnings Call, Oct 29, 2026 | |
| 26/10 | Cyclopharm Limited Announces Retirement of Dianne Angus as Non-Executive Director, Effective November 30, 2026 | CI |
| Market Cap | 53.44M 37.61M 33.69M 31.08M 28.12M 52.59M 3.58B 371M 148M 1.87B 141M 138M 5.94B | P/E 2026 * |
-3.02x | P/E 2027 * | -4.74x |
|---|---|---|---|---|---|
| Enterprise Value | 53.44M 37.61M 33.69M 31.08M 28.12M 52.59M 3.58B 371M 148M 1.87B 141M 138M 5.94B | EV / Sales 2026 * |
1.44x | EV / Sales 2027 * | 1.13x |
| Free-Float |
51.17% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Cyclopharm Limited
| 1 day | +10.39% | ||
| 1 week | +18.06% | ||
| Current month | -6.59% | ||
| 1 month | -6.59% | ||
| 3 months | -28.57% | ||
| 6 months | -42.57% | ||
| Current year | -56.63% |
| 1 week | 0.36 |  | 0.46 |
| 1 month | 0.33 | | 0.52 |
| Current year | 0.33 | | 1.29 |
| 1 year | 0.33 | | 1.29 |
| 3 years | 0.33 | | 2.5 |
| 5 years | 0.33 | | 3.15 |
| 10 years | 0.33 | | 3.45 |
| Manager | Title | Age | Since |
|---|---|---|---|
James McBrayer
CEO | Chief Executive Officer | 60 | 21/10/2009 |
Jason Smith
DFI | Director of Finance/CFO | - | 26/02/2024 |
Mathew Farag
COO | Chief Operating Officer | - | 01/01/2017 |
| Director | Title | Age | Since |
|---|---|---|---|
James McBrayer
BRD | Director/Board Member | 60 | 03/06/2008 |
Dianne Angus
BRD | Director/Board Member | 65 | 10/08/2021 |
Gregory King
BRD | Director/Board Member | - | 27/09/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 12/3/26 | Buy | Director | 21,052 | 0.0175% | ||
| 12/3/26 | Buy | Director | 5,263 | 0.0044% | ||
| 12/3/26 | Buy | Director | 21,052 | 0.0175% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +10.39% | +18.06% | -33.59% | -79.06% | 34.07M | |
| -1.85% | +3.60% | +25.50% | +60.81% | 262B | |
| -1.89% | +0.66% | +7.89% | +25.35% | 167B | |
| -2.07% | -2.90% | -17.14% | +69.90% | 156B | |
| +0.53% | -6.42% | -57.49% | -14.58% | 61.87B | |
| -1.11% | +5.10% | +12.14% | +50.12% | 54.44B | |
| -0.10% | +2.39% | -12.03% | -6.36% | 53.3B | |
| -3.87% | +0.87% | +21.78% | +72.56% | 51.07B | |
| +0.30% | -3.78% | +9.05% | +63.35% | 50.25B | |
| -3.49% | +2.18% | +35.19% | +95.84% | 47.17B | |
| Average | -0.37% | +2.21% | -0.87% | +33.79% | 90.26B | |
| Weighted average by Cap. | -1.71% | +2.44% | +5.57% | +48.68% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 37.2M 26.18M 23.45M 21.63M 19.58M 36.61M 2.49B 258M 103M 1.3B 98.25M 96.16M 4.13B | 47.2M 33.22M 29.75M 27.45M 24.84M 46.45M 3.16B 327M 131M 1.66B 125M 122M 5.24B |
| Net income | -17.4M -12.25M -10.97M -10.12M -9.16M -17.12M -1.17B -121M -48.16M -610M -45.96M -44.98M -1.93B | -12.4M -8.73M -7.82M -7.21M -6.53M -12.2M -831M -86.03M -34.32M -435M -32.75M -32.05M -1.38B |
| Net Debt | - | - |
Employees
104
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/10/26 | $0.4250 | +10.39% | 111,297 |
| 29/10/26 | $0.3850 | +4.05% | 138,069 |
| 28/10/26 | $0.3700 | 0.00% | 33,757 |
| 27/10/26 | $0.3700 | -1.33% | 2,410 |
| 23/10/26 | $0.3750 | +4.17% | 1,209 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.2710USD
Average target price
0.7170USD
Spread / Average Target
+164.62%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CYC Stock
Select your edition
All financial news and data tailored to specific country editions
